title: Can risk-adapted treatment recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients?
authors.affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
authors.forename: R Michael
authors.initials: RM
authors.lastname: Tuttle
authors.forename: James A
authors.initials: JA
authors.lastname: Fagin
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D009367:Neoplasm Staging; D012307:Risk Factors; D013964:Thyroid Neoplasms / Q000473:pathology / Q000628:therapy*